139 related articles for article (PubMed ID: 38125667)
1. Reactive Keratoacanthoma Following Treatment with 5-Fluorouracil.
Paradkar KA; Plotner AN
J Clin Aesthet Dermatol; 2023 Dec; 16(12):55-56. PubMed ID: 38125667
[TBL] [Abstract][Full Text] [Related]
2. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Follow-Up of a Randomized Controlled Trial of 0.5% and 5% 5-Fluorouracil After Microneedling for Treatment of Facial Actinic Keratoses.
Kalil CLPV; Reinehr CPH; Bakos RM
Dermatol Surg; 2022 Mar; 48(3):293-298. PubMed ID: 35125436
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
5. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
7. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
Beatson M; Siegel JA; Chren MM; Weinstock MA
Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
[TBL] [Abstract][Full Text] [Related]
8. Current perspective on actinic keratosis: a review.
Siegel JA; Korgavkar K; Weinstock MA
Br J Dermatol; 2017 Aug; 177(2):350-358. PubMed ID: 27500794
[TBL] [Abstract][Full Text] [Related]
9. Treatment of keratoacanthoma with topical application of fluorouracil.
Goette DK; Odom RB; Arrott JW; Diakon NC; Horn RT
Arch Dermatol; 1982 May; 118(5):309-11. PubMed ID: 7082021
[TBL] [Abstract][Full Text] [Related]
10. Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis.
Stockfleth E; Bégeault N; Delarue A
Dermatol Ther (Heidelb); 2022 Feb; 12(2):467-479. PubMed ID: 34954811
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of keratoacanthoma with intralesional fluorouracil.
Goette DK; Odom RB
J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978
[TBL] [Abstract][Full Text] [Related]
12. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
13. Relative Efficacy of Nonoperative Treatment of Keratoacanthomas.
Seger EW; Tarantino IS; Neill BC; Wang T
J Cutan Med Surg; 2020; 24(1):41-46. PubMed ID: 31591899
[TBL] [Abstract][Full Text] [Related]
14. Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis.
Singh R; McCain S; Feldman SR
JMIR Dermatol; 2023 Feb; 6():e39988. PubMed ID: 37632916
[TBL] [Abstract][Full Text] [Related]
15. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
16. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
17. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
18. 0.5% 5-Fluorouracil/10% Salicylic Acid for the Treatment of Distal Actinic Keratoses Under Daily Practice Conditions.
Iglesias-Puzas A; Batalla A; Suh-Oh HJ; Flórez A
J Drugs Dermatol; 2019 Mar; 18(3):285-288. PubMed ID: 30909350
[TBL] [Abstract][Full Text] [Related]
19. Actinic keratosis. Current treatment options.
Jeffes EW; Tang EH
Am J Clin Dermatol; 2000; 1(3):167-79. PubMed ID: 11702298
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
